Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Board Change

22 Sep 2015 07:02

RNS Number : 7407Z
Regenersis PLC
22 September 2015
 



22 September 2015

 

REGENERSIS PLC

("Regenersis")

 

DIRECTORS' DECLARATIONS

 

Regenersis Plc (AIM:RGS.L, "Regenersis", the "Group") is pleased to announce the following Board appointments from 1 October 2015:

 

Ian Donald Powell will join the main Board as Executive Director in the role of CEO of Aftermarket Services. Mr Powell, age 54, was previously Group Managing Director of Regenersis in the period 2011-2013, prior to that he has been CEO of Chapelthorpe plc, and Chairman Chairman/Chief Executive of several businesses where he held material equity stakes. In the last 5 years, Mr Powell has held the following Directorships:

Current directorships

Past directorships

Tangram Ventures Limited

Chapelthorpe plc

Tangram Trading Inc

 

 

Patrick J Clawson will join the main Board as Executive Director as CEO of Digital Security Software. Mr Clawson, aged 51, was previously Chairman/CEO of Lumension, a US endpoint security software business. In the last 5 years, Mr Clawson has held the following Directorships:

Current directorships

Past directorships

Blancco OY Limited

Cyberguard Inc

Xcaliber Technologies LLC

Lumension Inc

K is for Kids Foundation

 

Thomas Kevin Skelton will join the main Board as Non Executive Director. Mr Skelton, aged 54, is the current CEO of Surescripts, a market leading software business which enables over six billion annual e-prescriptions and other healthcare transactions in the USA. Until recently, he had been a non-executive director of Micro Focus International Plc since 2006. Mr Skelton has no current shareholding or share option or incentive plan awards in Regenersis.

Current directorships

Past directorships

Surescripts LLC

Microfocus International Plc

 

Regenersis confirms that there are no further disclosures required in accordance with paragraph (g) of Schedule Two, AIM Rules for Companies.

 

Enquiries:

 

Regenersis Plc +44 (0) 20 3657 7000

Matthew Peacock, Executive Chairman

Jog Dhody, Chief Financial Officer

 

Peel Hunt LLP (Nomad and Joint Broker) +44 (0) 20 7418 8900

Richard Kauffer

Edward Fox

 

Panmure Gordon (UK) Limited (Joint Broker) +44 (0) 20 7886 2500

Charles Leigh Pemberton

Tulchan Communications +44 (0) 20 7353 4200

Tom Murray

Victoria Huxster

 

Regenersis provides a suite of product life cycle support services designed to help companies and their customers successfully deploy, protect, sustain, retire and re-use digital technology.

 

www.regenersis.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADBGDCSDDBGUB
Date   Source Headline
3rd Oct 20232:12 pmPRNForm 8.3 - Blancco Technology Group Plc
3rd Oct 20237:00 amRNSAcceptance Level Update
2nd Oct 20232:49 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
2nd Oct 202311:12 amRNSForm 8.3 - Blancco Technology Group PLC
2nd Oct 20237:00 amRNSACCEPTANCE LEVEL UPDATE
28th Sep 20232:07 pmRNSForm 8.3 - Blancco Technology Group plc
28th Sep 202311:52 amRNSForm 8.3 - Blancco Technology Group PLC
28th Sep 202310:22 amRNSForm 8.3 - Blancco Technology Group PLC
27th Sep 20232:03 pmRNSForm 8.3 - Blancco Technology Group PLC
27th Sep 20231:16 pmPRNForm 8.3 - Blancco Technology Group Plc
27th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
27th Sep 202311:40 amRNSForm 8.3 - Blancco Technology Group plc
27th Sep 202311:11 amRNSNotification of Major Holdings
27th Sep 20237:00 amRNSAcceptance Level Update
27th Sep 20237:00 amRNSForm 8.3 - Blancco Technology Group PLC
26th Sep 202311:16 amRNSForm 8.3 - Blancco Technology Group PLC
22nd Sep 20232:19 pmRNSForm 8.3 - Blancco Technology Group plc
22nd Sep 202311:44 amRNSForm 8.3 - Blancco Technology Group plc
20th Sep 20231:22 pmRNSForm 8.3 - Blancco Technology Group plc
20th Sep 202311:31 amRNSForm 8.3 - Blancco Technology Group PLC
20th Sep 20237:00 amRNSAcceptance Level Update
19th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
18th Sep 20232:19 pmRNSForm 8.3 - Blanco Technology Group
15th Sep 20232:10 pmPRNForm 8.3 - Blancco Technology Group Plc
15th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
15th Sep 202310:25 amGNWForm 8.3 - Blancco Technology Group Plc
14th Sep 20236:26 pmBUSForm 8.3 - Blancco Technology Group plc
14th Sep 20239:32 amGNWForm 8.3 - Blancco Technology Group Plc
13th Sep 20237:00 amRNSAcceptance Level Update
8th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
8th Sep 202311:24 amRNSForm 8.3 - Blancco Technology Group PLC
6th Sep 20237:00 amRNSAcceptance Level Update
5th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
4th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
1st Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
1st Sep 202311:21 amRNSForm 8.3 - Blancco Technology Group PLC
1st Sep 20239:48 amRNSForm 8.3 - Blancco Technology Group PLC
31st Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
31st Aug 20239:00 amBUSForm 8.3 - Blancco Technology Group PLC
30th Aug 20237:00 amRNSAcceptance Level Update
22nd Aug 202310:48 amRNSForm 8.3 - Blancco Technology Group PLC
18th Aug 202311:07 amGNWForm 8.3 - Blancco Technology Group Plc
16th Aug 202310:33 amRNSFORM 8 (OPD) - Blancco Technology Group plc
14th Aug 20237:00 amBUSForm 8.3 - Blancco Technology Group plc
11th Aug 202311:29 amBUSForm 8.3 - Blancco Technology Group Plc
9th Aug 20233:37 pmRNSForm 8.3 - Blancco Technology Group PLC
9th Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
8th Aug 20234:59 pmRNSPublication and Posting of Offer Document
8th Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
7th Aug 20239:34 amGNWForm 8.3 - Blancco Technology Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.